Biotechnology 

Fast therapeutic insights with the in vivo data you need

Get robust and translatable pre-clinical data with our world-leading expertise and innovative approach

We help our global biotech partners gain early in vivo advances to inform and enrich their drug and therapeutic pipeline in short timeframes (weeks). We combine the inherent advantages of C. elegans as a model organism, with our world-leading expertise for validated, regulation-free testing with human translatability 1-6. We effectively build on in vitro studies, de-risk your project, and reduce the need for mammalian testing.

Unique technology and expertise

Our unique automated WormGazerTM technology provides rich multi-end point in vivo data to help you generate IP for your therapeutics. You partner with our interdisciplinary team who bring 80+ years joint experience to enable the optimal assay design using C. elegans as a model.

We work efficiently to bring you diverse data to meet your requirements for efficacy, early toxicology, phenotypic and functional end-points, drug combinations, mechanism of action, target validation and identification. 

Early in vivo insights to inform and enrich your drug discovery pipeline 

✓ De-risk and reduce rodent testing and regulation, saving time and resources

✓ A validated1-6, cheaper, 3R compliant model for acute and chronic drug testing

✓ Fast, rich data in weeks, with unique automated WormGazerTM technology 

✓ Bespoke CRO assay development and proof of concept studies 

✓ Expert interdisciplinary team with 80+ years joint experience as partners 

✓ Seamless and collaborative approach to replicate in-house R&D✓  Well-structured, robust data for all in-house formats, publication, patents and investors

Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to develop therapeutics for age-related disease, works with Magnitude Biosciences to test their compound, FAB001, to test their hypothesis on the nature of ageing.

"We have formed an incredible partnership, …with novel information on our formulations. All of this will be reflected in the publications of several papers and the filing of several patents. We hope to maintain this collaboration in future projects and keep developing new formulations to help human health."

Gerald Dard, Managing Director, AB Biotek HNH 

Get in touch today to find out how we can 
support you to accelerate your research

Privacy Policy
This field is for validation purposes and should be left unchanged.

SERVICES

Contract lab services for 
your research area

Our customised C. elegans studies help industry leaders generate high-quality, 
reproducible data to answer their research questions in these areas.

Microbiome

A powerful whole
organism model for
microbiome research

Neurodegeneration

A proven whole organism model for neurodegenerative disease
research

Toxicity

A powerful whole organism model for detecting toxicity for the environment and human health

Ageing

A powerful whole
organism model for accelerating ageing research

Transgenics

We can generate C. elegans strains tailored to the exact needs of your project.

Slide
Ageing

A powerful whole
organism model for accelerating ageing research

Slide
Microbiome

A powerful whole organism model for
microbiome research

Slide
Neurodegeneration

A proven whole organism model for neurodegenerative disease
research

Slide
Toxicity

A powerful whole organism model for detecting toxicity for the environment and human health

Slide
Transgenics

We can generate C. elegans strains tailored to the exact needs of your project.

previous arrow
previous arrow
next arrow
next arrow

CONTACT US

Get in touch today to find out how we can support you
to accelerate your research